Surv BioPharma

Developer of gene therapies designed to improve the treatment of various diseases. The company's platform utilizes drug delivery systems and targeted therapy approaches, aiming to enhance drug efficac...

Healthcare

Kagoshima, Japan

Founded 2022

12 employees

Website

Valuation

$28.8M

Market implied

Share Price

N/A

Total Raised

$17.2M

Last Round

N/A

Investors

+9 other investors

View all 9 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Surv BioPharma's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required